0001144204-15-067227.txt : 20151120 0001144204-15-067227.hdr.sgml : 20151120 20151120160239 ACCESSION NUMBER: 0001144204-15-067227 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20151117 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20151120 DATE AS OF CHANGE: 20151120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SKYSTAR BIO-PHARMACEUTICAL CO CENTRAL INDEX KEY: 0001076939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330901534 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34394 FILM NUMBER: 151246633 BUSINESS ADDRESS: STREET 1: RM 10601, JIEZUO PLAZA, NO. 4 STREET 2: FENGHUI ROAD SOUTH, GAOXIN DISTRICT CITY: XIAN PROVINCE STATE: F4 ZIP: 00000 BUSINESS PHONE: 407-645-4433 MAIL ADDRESS: STREET 1: RM 10601, JIEZUO PLAZA, NO. 4 STREET 2: FENGHUI ROAD SOUTH, GAOXIN DISTRICT CITY: XIAN PROVINCE STATE: F4 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: CYBER GROUP NETWORK CORP DATE OF NAME CHANGE: 20000711 8-K 1 v425312_8-k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

______________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 17, 2015

SKYSTAR BIO-PHARMACEUTICAL COMPANY

(Exact Name of Registrant as Specified in Its Charter)

Nevada

(State or Other Jurisdiction of Incorporation)

001-34394		33-0901534
(Commission File Number)		(IRS Employer Identification No.)

4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an Shaanxi Province, P.R. China		n/a
(Address of Principal Executive Offices)		(Zip Code)

(8629) 8819-3188

(Registrant’s Telephone Number, Including Area Code)

n/a

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On November 17, 2015, Skystar Bio-Pharmaceutical Company (the “Company”) received a notification from The Nasdaq Stock Market (“Nasdaq”) informing the Company that because it had not filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2015(the “Quarterly Report”), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1).

The Company previously disclosed a notification from Nasdaq informing the Company that is was subject to delisting because it failed to comply with Nasdaq’s filing requirements set forth in Listing Rule 5250(c)(1) because it failed to file its Form 10-K for the fiscal year ended December 31, 2014, and Forms 10-Q for the periods ended March 31, and June 30, 2015. The failure to file the Quarterly Report constitutes an additional basis for delisting. The Company also previously disclosed that Nasdaq had notified the Company of two additional, and separate, bases for delisting under Listing Rule 5250(b)(1) (failure to disclose material non-public information) and Listing Rule 5101 (public interest concerns).

The Company has a hearing scheduled for December 3, 2015 for the hearing panel to review the delisting determination.

Item 8.01

Other Events

On November 19, 2015, the Company issued a press release relating to the foregoing event, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits.

99.1

Press release dated November 19, 2015.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 20, 2015

	SKYSTAR BIO-PHARMACEUTICAL COMPANY


	By:	/s/ Bing Mei
	Name: Bing Mei
	Title: Chief Financial Officer

EX-99.1 2 v425312_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION LETTER

Xi’an, China, November 19, 2015 – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced that on November 17, 2015, it received a letter from NASDAQ Stock Market indicating that that Skystar failed to comply with Nasdaq’s filing requirement set forth in Listing Rule 5250(c)(1) (the “Rule”) because it failed to file its Form 10-Q for the fiscal quarter ended September 30, 2015 (the “Quarterly Report”).

The Company has a hearing scheduled for December 3, 2015 for the hearing panel to review the delisting determination.

About Skystar Bio-Pharmaceutical Company

Skystar is a China-based developer, manufacturer and distributor of veterinary healthcare and medical care products. Skystar has four product lines: veterinary medicines, probiotics, vaccines and feed additives formulated and packaged in house across several modern manufacturing and distributions facilities. Skystar's distribution network includes almost 3,000 distribution agents of which 360 are franchised stores with exclusivity agreements covering 29 provinces throughout China. For additional information, please visit http://www.skystarbio-pharmaceutical.com.

Safe Harbor Statements

When used in this release, the words "intends," "believes," "anticipated" and "expects" and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, without limitation, the Company’s ability to complete its IgG kit effort as well as other related efforts at the Huxian facilities, the Company’s ability to timely, effectively and accurately assess the efficacy and commercial potential of any technologies that may results from such R&D efforts, the Company’s ability to timely and effectively commercialize any such technologies. The Company undertakes no obligation to publicly release the result of any revision to these forward-looking statements which may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact:

Skystar Bio-Pharmaceutical Company
Scott Cramer
Director - Corporate Development & U.S. Representative
(407) 645-4433

GRAPHIC 3 image_001.jpg GRAPHIC begin 644 image_001.jpg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